Emeritus Corporation (Emeritus) is engaged in operations of senior living communities in the United States. The Company owns and operates a portfolio of communities providing services to its residents, including independent living, assisted living, specialized memory care, and, to a lesser extent, skilled nursing care. The Company provides a variety of supportive living services in a professionally staffed environment that enables seniors to live with dignity and independence. During the year ending December 31, 2012, the Company added home healthcare to its service offerings, through its acquisition of Florida-based Nurse on Call, Inc. (NOC). As of December 31, 2012, the Company operated 483 senior living communities in 45 states. The communities consisted of approximately 43,000 residential rooms or suites (collectively units) with a resident capacity for approximately 50,100 residents.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Health Care Providers & Services
- Sub-Industry: Health Care Facilities
- Symbol: NYSE:ESC
- CUSIP: 29100510
- Web: N/A
- Trailing P/E Ratio:
- Foreward P/E Ratio: 13.07
- P/E Growth:
Frequently Asked Questions for Emeritus (NYSE:ESC)
What is Emeritus' stock symbol?
Emeritus trades on the New York Stock Exchange (NYSE) under the ticker symbol "ESC."
Who are some of Emeritus' key competitors?
Some companies that are related to Emeritus include Merck KGaA (MKGAY), Hospira (HSP), Omnicare (OCR), Health Net (HNT), WuXi PharmaTech (Cayman) (WX), Hanger (HGR), SIGA Technologies (SIGA), Nobilis Health Corp (HLTH), Verastem (VSTM), Palatin Technologies (PTN), KaloBios Pharmaceuticals (KBIO), AdCare Health Systems (ADK), Capricor Therapeutics (CAPR), 3SBio (SSRX), Alexza Pharmaceuticals (ALXA), Allergan plc (WPI), Allergan plc (ACT) and Allos Therapeutics (ALTH).
How do I buy Emeritus stock?
Shares of Emeritus can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Emeritus stock cost?
One share of Emeritus stock can currently be purchased for approximately $33.46.
Consensus Ratings for Emeritus (NYSE:ESC) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Emeritus (NYSE:ESC)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Emeritus (NYSE:ESC)Earnings History by Quarter for Emeritus (NYSE:ESC)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/1/2013||Q2 2013||($0.48)||($0.66)||$477.38 million||$475.90 million||View||N/A|
|5/2/2013||Q1 2013||($0.56)||($0.88)||$464.96 million||$472.36 million||View||N/A|
|2/28/2013||Q4 2012||($0.44)||$0.40||$403.45 million||$412.10 million||View||N/A|
|11/5/2012||Q312||($0.31)||($0.30)||$337.76 million||$381.12 million||View||N/A|
Earnings Estimates for Emeritus (NYSE:ESC)
Current Year EPS Consensus Estimate: $2.18 EPS
Next Year EPS Consensus Estimate: $2.56 EPS
Dividend History for Emeritus (NYSE:ESC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Emeritus (NYSE:ESC)Insider Trades by Quarter for Emeritus (NYSE:ESC)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|5/29/2014||Claro Budgie Bautista Amparo||EVP||Sell||31,865||$31.22||$994,825.30|| |
|5/29/2014||James C A Hyatt||COO||Sell||130,690||$31.27||$4,086,676.30|| |
|5/29/2014||Robert C Bateman||CFO||Sell||155,512||$31.09||$4,834,868.08|| |
|5/29/2014||Susan Coppola||SVP||Sell||1,874||$31.30||$58,656.20|| |
|3/4/2014||Melanie Cobb Werdel||EVP||Sell||40,000||$32.00||$1,280,000.00|| |
|3/3/2014||James Hyatt||COO||Sell||14,038||$31.72||$445,285.36|| |
|3/3/2014||Melanie Cobb Werdel||EVP||Sell||8,923||$31.72||$283,037.56|| |
|2/21/2014||Claro Budgie Bautista Amparo||EVP||Sell||30,000||$29.50||$885,000.00|| |
|2/21/2014||James Hyatt||COO||Sell||20,000||$29.50||$590,000.00|| |
|5/14/2013||Jayne E Sallerson||EVP||Sell||25,750||$26.79||$689,842.50|| |
|5/14/2013||John Anthony Cincotta||SVP||Sell||18,950||$26.85||$508,807.50|| |
|5/13/2013||Christopher M Belford||SVP||Sell||33,000||$26.61||$878,130.00|| |
|5/13/2013||Claro Budgie Bautista Amparo||EVP||Sell||8,750||$27.03||$236,512.50|| |
|5/13/2013||James C A Hyatt||COO||Sell||34,427||$26.96||$928,151.92|| |
Headline Trends for Emeritus (NYSE:ESC)
Latest Headlines for Emeritus (NYSE:ESC)
Emeritus (ESC) Chart for Friday, May, 26, 2017